These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29908369)

  • 21. Predictive value of Tpeak-Tend interval for ventricular arrhythmia and mortality in heart failure patients with an implantable cardioverter-defibrillator: A cohort study.
    Xue C; Hua W; Cai C; Ding LG; Niu HX; Fan XH; Liu ZM; Gu M; Zhao YZ; Zhang S
    Medicine (Baltimore); 2019 Dec; 98(49):e18080. PubMed ID: 31804316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.
    Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V
    Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators.
    Kawamura M; Arai S; Yoshikawa K; Gokan T; Ogawa K; Ochi A; Onishi Y; Munetsugu Y; Ito H; Onuki T; Kobayashi Y; Shinke T
    Clin Cardiol; 2019 Jul; 42(7):670-677. PubMed ID: 31056759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events.
    Szepietowska B; Polonsky B; Sherazi S; Biton Y; Kutyifa V; McNitt S; Aktas M; Moss AJ; Zareba W
    Cardiovasc Diabetol; 2016 Jul; 15():93. PubMed ID: 27388610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Cardiac Resynchronization Therapy in Patients With Insulin-Treated Diabetes Mellitus.
    Szepietowska B; Kutyifa V; Ruwald MH; Solomon SD; Ruwald AC; McNitt S; Polonsky B; Thomas S; Moss AJ; Zareba W
    Am J Cardiol; 2015 Aug; 116(3):393-9. PubMed ID: 26048851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Effects of Epicardial and Endocardial Cardiac Resynchronization Therapy on Transmural Dispersion of Repolarization.
    Özcan EE; Szilagyi S; Sallo Z; Molnar L; Zima E; Szeplaki G; Osztheimer I; Öztürk A; Merkely B; Geller L
    Pacing Clin Electrophysiol; 2015 Sep; 38(9):1099-105. PubMed ID: 26096799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients.
    Husaini M; Biton Y; Stair B; Moss AJ; Biering-Sørensen T; Solomon S; McNitt S; Polonsky B; Zareba W; Barsheshet A; Kutyifa V
    Cardiol J; 2016; 23(4):437-45. PubMed ID: 27320956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of ventricular tachyarrhythmias by intracardiac repolarization variability analysis.
    Tereshchenko LG; Fetics BJ; Domitrovich PP; Lindsay BD; Berger RD
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):276-84. PubMed ID: 19808478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cardiac resynchronization therapy on beat-to-beat T-wave amplitude variability.
    Žižek D; Cvijić M; Tasič J; Jan M; Frljak S; Zupan I
    Europace; 2012 Nov; 14(11):1646-52. PubMed ID: 22423254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure.
    Gold MR; Linde C; Abraham WT; Gardiwal A; Daubert JC
    Heart Rhythm; 2011 May; 8(5):679-84. PubMed ID: 21185401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postimplantation ventricular ectopic burden and clinical outcomes in cardiac resynchronization therapy-defibrillator patients: a MADIT-CRT substudy.
    Ruwald AC; Aktas MK; Ruwald MH; Kutyifa V; McNitt S; Jons C; Mittal S; Steinberg JS; Daubert JP; Moss AJ; Zareba W
    Ann Noninvasive Electrocardiol; 2018 Mar; 23(2):e12491. PubMed ID: 28940909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
    Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
    J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Prognostic Significance of Ventricular Repolarization Dispersion in Patients with Cardiac Sarcoidosis.
    Kobayashi Y; Nagai T; Takenaka S; Kato Y; Komoriyama H; Nagano N; Kamiya K; Konishi T; Sato T; Omote K; Tsujinaga S; Iwano H; Kusano K; Yasuda S; Ogawa H; Ishibashi-Ueda H; Anzai T
    Am J Cardiol; 2021 Aug; 152():125-131. PubMed ID: 34127248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
    Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
    Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defibillator electrogram T wave alternans as a predictor of spontaneous ventricular tachyarrhythmias in defibrillator recipients.
    Kim JW; Pak HN; Park JH; Nam GB; Kim SK; Lee HS; Jang JK; Choi JI; Kim YH
    Circ J; 2009 Jan; 73(1):55-62. PubMed ID: 19039191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.
    Levine YC; Matos J; Rosenberg MA; Manning WJ; Josephson ME; Buxton AE
    Heart Rhythm; 2016 Feb; 13(2):490-7. PubMed ID: 26409099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic importance of postoperative QRS widening in patients with heart failure receiving cardiac resynchronization therapy.
    Menet A; Bardet-Bouchery H; Guyomar Y; Graux P; Delelis F; Castel AL; Heuls S; Cuvelier E; Gevaert C; Ennezat PV; Tribouilloy C; Maréchaux S
    Heart Rhythm; 2016 Aug; 13(8):1636-43. PubMed ID: 27236025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.